Therapeutic options in post-transplant lymphoproliferative disorders. - Wikidata - wikimedia - TriplyDB

Therapeutic options in post-transplant lymphoproliferative disorders.

Therapeutic options in post-transplant lymphoproliferative disorders.

http://www.wikidata.org/entity/Q30455714

about

Blood disorders typically associated with renal transplantation Proliferative glomerulonephritis with monoclonal IgG deposits in two kidney allografts successfully treated with rituximab.Treatment of post-transplantation lymphoproliferative disorders after kidney transplant with rituximab and conversion to m-TOR inhibitor.Virus-specific T-cell therapy in solid organ transplantation.Occurrence and prognostic relevance of CD30 expression in post-transplant lymphoproliferative disorders.Posttransplant Lymphoproliferative Disease Presenting as an Extracranial Mass.De novo glomerular diseases after renal transplantation: How is it different from recurrent glomerular diseases?

P2860

Q33421793-D9B83582-E2AB-4A83-AD37-E9B50ED582AB Q33783017-34FCB592-9C85-4578-A5F3-AC99786EAE8F Q37679263-0440456F-D7F4-4940-B8B5-AE4EB5AE5774 Q38568902-B3B0CFF5-414E-4579-92C3-BF6D52868A1B Q41728703-51F03F45-2E30-4BF0-A5E1-1FEDE5E3A4B9 Q47137019-5D6A5491-F65B-4778-B90F-D11689BCC422 Q47172094-8F150BBC-40C4-4077-83E6-554C7BD4DFEB

P2860

Therapeutic options in post-transplant lymphoproliferative disorders.

http://www.wikidata.org/entity/Q30455714

description

2011 nî lūn-bûn

@nan

2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Therapeutic options in post-transplant lymphoproliferative disorders.

@ast

Therapeutic options in post-transplant lymphoproliferative disorders.

@en

type

label

Therapeutic options in post-transplant lymphoproliferative disorders.

@ast

Therapeutic options in post-transplant lymphoproliferative disorders.

@en

prefLabel

Therapeutic options in post-transplant lymphoproliferative disorders.

@ast

Therapeutic options in post-transplant lymphoproliferative disorders.

@en

P1433

Q30455714-90096718-071C-46F8-8726-F7DD69224DF7

P1476

Q30455714-6D0997A0-802D-41F9-A858-267BFBDBEA34

P2093

Q30455714-14E67668-7402-43BF-B562-F4F51DD3D7D7

P2860

Q30455714-00E78854-6DE9-4C18-B67E-3D9FB3C2D03C

Q30455714-01B25DF6-DF6E-4BCC-8BB8-CB60B11657CC

Q30455714-026D81D2-AA6C-42AD-ADCD-32FB47ABE2B6

Q30455714-05005E9B-5AA1-4FA4-8829-C90E933C159D

Q30455714-0AEDDA66-E5DE-441D-B4C6-C114C5E72ECD

Q30455714-0B984280-BD3F-4BAC-9D08-FBAC4B8B5C49

Q30455714-0F818681-A1D0-427B-9763-6341E290DB19

Q30455714-11084C59-EBCD-4087-894B-CC0F7BC8D93D

Q30455714-18053714-2E5C-43DE-BD06-98765AE68B9C

Q30455714-198BA3FA-7C24-48AD-BFCE-5528420824F9

P304

Q30455714-23460C1A-F3B7-40F5-9F63-AC39D0BBA07A

P31

Q30455714-CDD9C808-6DB2-4C35-974E-5B649A868DD8

P356

Q30455714-AEF95A88-DDAB-42B0-8989-0989456CD438

P433

Q30455714-539CAAF9-2E21-4FFC-ABCD-C42E7A733166

P478

Q30455714-4DAA33D8-1919-4DC1-8C8A-0247C1B6E1AC

P50

Q30455714-A7B8B733-D251-4C7D-BC52-8D0785E38C76

P577

Q30455714-0328D748-6B35-41D1-8B0C-72B2E00A5C58

P5875

Q30455714-F89091A5-A233-4DC3-BF06-6B1EF12E1E55

P698

Q30455714-4E68FCB0-4EC0-4D52-B580-02735859F73C

P932

Q30455714-C315B645-E25F-43F8-AED2-1936F3E618D9

P356

2040620711412417

P1433

Therapeutic advances in hematology

P1476

Therapeutic options in post-transplant lymphoproliferative disorders.

@en

P2093

Heiner Zimmermann

http://www.w3.org/2001/XMLSchema#string

P2860

Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report.

A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.

Successful outcome with a "quintuple approach" of posttransplant lymphoproliferative disorder.

Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder.

Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era.

Malignant lymphomas in transplantation patients.

Diagnosis and treatment of transplant-related lymphoma.

Lymphoproliferative disorders after liver transplantation: imaging features.

Epstein-Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease.

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

P304

393-407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2040620711412417

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236106962

http://www.w3.org/2001/XMLSchema#string

P698

23556105

http://www.w3.org/2001/XMLSchema#string

P932

3573421

http://www.w3.org/2001/XMLSchema#string